Advanced search
Publication Cover
Topics in Stroke Rehabilitation Volume 7, 2000 - Issue 1: Contemporary Issues in Stroke Rehabilitation
Submit an article Journal homepage
12
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Neuroprotective Agents in Acute Ischemic Stroke

Nanette H. HockStanford UniversityDepartment of Neurology and Neurological Sciences, The Stanford Stroke Center, Palo Alto, California
Pages 53-61 | Published online: 02 Feb 2015

REFERENCES

  • Albers GW. Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia. Clin Neuropharmacol. 1990;13:177–197.
  • Rothman SM, Olney JW. Glutamate and the pathophysi-ology of hypoxic-ischemic brain damage. Ann Neurol. 1986;19:105–111.
  • Choi DW, Maullucci-Gedde MA, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci. 1987;7:357–368.
  • Choi DW, Koh J, Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci. 1988; 8(1):185–196.
  • Frandsen A, Drejer J, Schousboe A. Direct evidence that excitotoxicity in cultured neurons is mediated via N-methyl-D-aspartate (NMDA) as well as non-NMDA re-ceptors. J Neurochem. 1989;53(1):297–299.
  • Silverstein FS, Buchanan K, Johnston MV. Perinatal hypoxia-ischemia disrupts striatal high affinity [3H] glutamate uptake into synaptosomes. J Neurochem. 1986; 47:1614–1619.
  • Goldberg MP, Kurth MC, Giffard RG, Choi DW. Cal-cium accumulation and intracellular calcium during in vitro "ischemia." Soc Neurosci Abstr. 1989;15:803.
  • Kogure K, Kato H. Neurochemistry of stroke. In: Barnett HJM, Stein BM, Mohr JP, Yatsu FM, eds. Stroke: Pat ho-physiology, Diagnosis, and Management, 2nd ed. London: Churchill Livingstone;1992:69–101.
  • Jaffrey SR, Snyder SH. Nitric oxide: a neural messenger. Annu Rev Cell Dev Biol. 1995;11:417–440.
  • Faden AI. Opioids and nonopioid mechanisms may con-tribute to dynorphin's pathophysiological actions in spi-nal cord injury. Ann Neurol. 1990;27(1):64–67.
  • Peters S, Koh J, Choi DW. Zinc selectivity blocks the action of N-methyl-D-aspartate on cortical neurons. Sci-ence. 1987;236: 589–593.
  • Westbrook GL, Mayer ML. Micromolar concentrations of zinc antagonize NMDA and GABA responses of hippocampal neurons. Nature. 1987;328:640–643.
  • Lodge D, Jines M, Fletcher E. Non-competitive antago-nists of N- methyl-D-aspartate. In: Watkins JC, Collingridge GL, eds. The NMDA Receptor. London: Oxford University Press;1989.
  • Kulagowski JJ, Leeson PD. Glycine-site NMDA receptor antagonists. Exp Opin Ther Patents. 1995;5(10):1061–1075.
  • Dixon R, Howes J, Gentile J, et al. Nalmefene: intrave-nous safety and kinetics of a new opioid antagonist Clin Pharmacol Ther. 1986;39(1):49–53.
  • Tietjen GE, Dombi T, Pusinelli WA, Becske T, Kugler AR, Mann ME. A double-blind, safety, and tolerance study of single intravenous doses of fosphenytoin in patients with acute ischemic stroke. Neurology. 1996;46(2):A424–A425.
  • Weiss GB. Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicholine. Life Sci. 1995;56(9):637–660.
  • Tazaki Y, Sakai F, Otomo E, Kutsuzawa T, Kameyama M, Omae T, Fujishima M, Sakuma A. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke. 1988;19(2):211–216.
  • Anonymous. Interneuron's citicholine beneficial in stroke. Scrip. February 27, 1996; 2106:21.
  • Diener HC, Hacke W, Hennerici M, Radberg J, Hanston L, De Keyser J for the Lubeluzole International Study Group. Lubeluzole in acute ischemic stroke: a double-blind, placebo-controlled phase II trial. Stroke. 1996;27(1):76–78.
  • Hacke W, Hennerici H, Hanston L, Diener HC. Lubeluzole: a new neuroprotectant agent in the treatment of acute ischemic stroke: results of a cardiovascular safety study in stroke patients. Neurology. 1996;46(2):A429.
  • Meldrum B. Protection against ischemic neuronal dam-age by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metab Rev. 1990;2:27–57.
  • Cross AJ, Jones JA, Baldwin HA, Green AR. Neuro-protective activity of clomethiazole following transient forebrain ischemia in the gerbil. Br J Pharmacol. 1991;104:406–411.
  • Vincens M, Enjalbert A, Lloyd K, et al. Evidence that clomethiazole interacts with the macromolecular GABAA-receptor complex in the central nervous system and in the anterior pituitary gland. Naundyn Schmidebergs Arch Pharmacol. 1989; 339:397�402.
  • Cross AJ, Stirling JM, Robinson TN, BowenDM, Francis PT, Green AR. The modulation by clomethiazole of the GABAA-receptor complex in rat brain. Br J Pharmacol. 1989;98:284–290.
  • Lyden PD. GABA and neuroprotection. In: Cross AJ, Green AR, eds. Neuroprotective Agents and Cerebral Ischemia. London: AP Ltd; 1997;233–258.
  • Hock NH. Neuroprotective and thrombolytic agents: advances in stroke treatment. J Neurosci Nurs. 1998;30:6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.